Markets:

Overview

News

Currencies

International

Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

16.27 +0.07 (+0.40%)

Streaming Delayed Price Updated: 10:05 AM EDT, Jul 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch + Lomb Corporation Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting

April 29, 2024

From Bausch + Lomb Corporation

Via Business Wire

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗

April 29, 2024

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Via Benzinga

Topics Stocks

Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes

April 25, 2024

From Bausch + Lomb Corporation

Via Business Wire

Barclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Know ↗

February 26, 2024

Via Benzinga

Earnings Scheduled For February 21, 2024 ↗

February 21, 2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.

Via Benzinga

Bausch & Lomb Earnings Preview ↗

February 20, 2024

Via Benzinga

The Latest Analyst Ratings for Bausch & Lomb ↗

December 04, 2023

Via Benzinga

Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs

April 18, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

April 15, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting

March 27, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch & Lomb Earnings Preview ↗

October 31, 2023

Via Benzinga

Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗

October 30, 2023

S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.

Via Benzinga

Topics Economy Stocks

Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors

February 28, 2024

From Bausch + Lomb Corporation

Via Business Wire

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 21, 2024

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...

Via Benzinga

Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses ↗

February 21, 2024

Bausch + Lomb achieves Q4 2023 sales of $1.173 billion, exceeding expectations with an 18% YoY growth. CEO Brent Saunders anticipates robust growth in 2024, projecting sales of $4.6-$4.7 billion and an...

Via Benzinga

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday ↗

February 21, 2024

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

February 21, 2024

From Emergent BioSolutions

Via GlobeNewswire

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance

February 21, 2024

From Bausch + Lomb Corporation

Via Business Wire

Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market ↗

February 21, 2024

The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think about the roadmap, an analyst said.

Via Benzinga

Topics Economy

Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month ↗

February 09, 2024

"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins...

Via Benzinga

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21

February 05, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery

January 08, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

November 15, 2023

From Bausch + Lomb Corporation

Via Business Wire

Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News' ↗

November 01, 2023

U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings.

Via Benzinga

Topics Economy Stocks

Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance

November 01, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting

October 26, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1

October 16, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting

October 04, 2023

From Bausch + Lomb

Via Business Wire

Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift ↗

October 03, 2023

Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.